GSK’s continued commitment to innovative respiratory research demonstrated in European Respiratory Society congress data presentations

GlaxoSmithKline plc (GSK) will provide updates on emerging areas of research with data from across its comprehensive respiratory portfolio of approved medicines, investigational programmes and scientific collaborations, at the European Respiratory Society (ERS) International Congress, 3rd -7th  September, London, UK. More than 30 abstracts from the company will be featured at the meeting.                                                                              

Highlights include data from a number of key studies:

http://www.gsk.com/en-gb/media/press-releases/2016/gsk-s-continued-commitment-to-innovative-respiratory-research-demonstrated-in-european-respiratory-society-congress-data-presentations/